# A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis

> **NCT05105750** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Atherosclerosis

## Interventions

- **DRUG:** aspirin 100 mg/d
- **DRUG:** indobufen 200 mg bid

## Key facts

- **NCT ID:** NCT05105750
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2022-03-20
- **Final completion:** 2022-03-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105750, "A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05105750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*